Sintx Technologies (SINT) Share-based Compensation (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.59% |
| Dec 31, 2025 | 19.23% |
| Sep 30, 2025 | 212.00% |
| Jun 30, 2025 | 872.22% |
| Mar 31, 2025 | 157.14% |
| Dec 31, 2024 | -30.00% |
| Sep 30, 2024 | -33.33% |
| Jun 30, 2024 | -70.00% |
| Mar 31, 2024 | -25.37% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -5.63% |
| Jun 30, 2023 | -17.44% |
| Mar 31, 2023 | -3.37% |
| Dec 31, 2022 | -1.11% |
| Sep 30, 2022 | 2.27% |
| Jun 30, 2022 | -13.73% |
| Mar 31, 2022 | 14.61% |
| Dec 31, 2021 | -14.42% |
| Sep 30, 2021 | 30.00% |
| Jun 30, 2021 | 122.22% |
| Mar 31, 2021 | 125.00% |
| Dec 31, 2018 | -60.00% |
| Sep 30, 2018 | -50.00% |
| Jun 30, 2018 | -58.33% |
| Mar 31, 2018 | -47.83% |
| Dec 31, 2017 | -14.81% |
| Sep 30, 2017 | -8.47% |
| Jun 30, 2017 | -1.67% |
| Mar 31, 2017 | -3.23% |
| Dec 31, 2016 | 10.71% |
| Sep 30, 2016 | -1.75% |
| Jun 30, 2016 | -35.23% |
| Mar 31, 2016 | -57.28% |
| Dec 31, 2015 | 114.58% |
| Sep 30, 2015 | 6.67% |
| Jun 30, 2015 | -86.36% |
| Mar 31, 2015 | 340.00% |
| Dec 31, 2014 | -92.60% |
| Sep 30, 2014 | -72.68% |
| Jun 30, 2014 | 428.49% |
| Mar 31, 2014 | 706.90% |
| Dec 31, 2013 | 357.89% |
| Sep 30, 2013 | -87.21% |
| Jun 30, 2013 | 545.65% |